MedPath

Clinical trial to test the efficacy and safety of topical application of IP in management of pain associated with muscles

Completed
Conditions
Acquired deformity of musculoskeletal system, unspecified,
Registration Number
CTRI/2019/11/021874
Lead Sponsor
Vasu Healthcare Pvt Ltd
Brief Summary

This study is aprospective, open label, single-center 14 days Clinical Study to evaluate theefficacy and Safety of Test formulation (Polyherbal Pain ReliefOintment) in the management of Moderateto severe pain.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
100
Inclusion Criteria
  • 1.Subjects of both genders with age ≥ 18 years. 2. Subjects who are willing to give written Informed Consent and willing to follow study procedures. 3.Subjects agreeing not to use any treatment for pain apart from the IP. 4. Subjects with documented diagnosis of moderate to severe pain with any of the condition, i.e., a.Sprains b.Shoulder and neck stiffness c.Backache d.Miscellaneous Musculo.
  • skeletal pain not classified above 5.Acute back pain, acute neck pain, acute musculoskeletal pain with no underlying pathology 6.Moderate to severe pain, as defined by an average 7-day pain score of greater than 4.0 on an 11-point numerical rating scale for pain intensity (NRS-PI). 7.All concurrent medications taken for any reason stable for 14 days.
Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Change Visual Analog Scale (VAS) score at Baseline and on day 1, 2, 3 and 7.7 days
2. Change in NPRS score at baseline and on Day 1, 2, 3 and 7.7 days
Secondary Outcome Measures
NameTimeMethod
1.Patient compliance questionnaire2.Any AE or SAE

Trial Locations

Locations (2)

KIMS

🇮🇳

Khordha, ORISSA, India

Santosh Hospital

🇮🇳

Bangalore, KARNATAKA, India

KIMS
🇮🇳Khordha, ORISSA, India
Dr Shubhransu Patro
Principal investigator
9861056729
dr.shubhransu@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.